文献速递神经肿瘤

儿童高级别胶质瘤中的端粒替代延长(ALT)可不伴ATRX突变发生,且富集于携带致病性胚系错配修复(MMR)变异的患者

Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.
PubMed 文献 · Neuro Oncol · 2023-01-01

研究对OpenPBTA中579例儿童脑肿瘤行C-circle分析(CCA),检出ALT者占6.9%(40/579),儿童高级别胶质瘤(pHGG)中ALT常见(24/63,38.1%),其他儿童脑肿瘤中低于3%。ALT阳性pHGG中仅部分伴ATRX突变,胚系MMR基因致病性变异与ALT发生显著相关。

要点

  • pHGG中ALT发生率为38.1%(24/63),其他儿童脑肿瘤中低于3%。
  • ALT阳性pHGG中50%伴ATRX突变,ALT阴性pHGG中30%伴ATRX突变。
  • 胚系MMR基因致病性变异与pHGG中ALT发生显著相关。

核心结论

  • ATRX仅在部分ALT阳性pHGG中突变,提示其他ATRX功能丧失机制或其他基因改变可能与这些患者ALT发生相关。
  • 胚系MMR变异与pHGG患者ALT发生相关。

研究设计与样本

  • 对OpenPBTA中579例具有配对肿瘤/正常全基因组测序的儿童脑肿瘤行C-circle分析(CCA)。
  • 在一部分肿瘤中用超亮端粒焦点原位验证ALT。
  • 用CCA验证TelomereHunter对ALT状态的计算预测,并将后续分析聚焦于儿童高级别胶质瘤(pHGG)。
  • 检查ALT是否与复发性体细胞或胚系改变相关。

主要发现

  • 579例儿童脑肿瘤中检出ALT者占6.9%(40/579)。
  • pHGG中ALT常见(24/63,38.1%),其他儿童脑肿瘤中发生频率低于3%。
  • 体细胞ATRX突变见于50%的ALT阳性pHGG和30%的ALT阴性pHGG。
  • 错配修复(MMR)基因中罕见的致病性胚系变异与ALT发生增加显著相关。

关键数值与推荐

  • ALT在pHGG中为24/63(38.1%),在其他儿童脑肿瘤中低于3%。
  • 体细胞ATRX突变在ALT阳性pHGG中为50%,在ALT阴性pHGG中为30%。
  • 579例儿童脑肿瘤中ALT检出40例(6.9%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To achieve replicative immortality, most cancers develop a telomere maintenance mechanism, such as reactivation of telomerase or alternative lengthening of telomeres (ALT). There are limited data on the prevalence and clinical significance of ALT in pediatric brain tumors, and ALT-directed therapy is not available. METHODS: We performed C-circle analysis (CCA) on 579 pediatric brain tumors that had corresponding tumor/normal whole genome sequencing through the Open Pediatric Brain Tumor Atlas (OpenPBTA). We detected ALT in 6.9% (n = 40/579) of these tumors and completed additional validation by ultrabright telomeric foci in situ on a subset of these tumors. We used CCA to validate TelomereHunter for computational prediction of ALT status and focus subsequent analyses on pediatric high-grade gliomas (pHGGs) Finally, we examined whether ALT is associated with recurrent somatic or germline alterations. RESULTS: ALT is common in pHGGs (n = 24/63, 38.1%), but occurs infrequently in other pediatric brain tumors (<3%). Somatic ATRX mutations occur in 50% of ALT+ pHGGs and in 30% of ALT- pHGGs. Rare pathogenic germline variants in mismatch repair (MMR) genes are significantly associated with an increased occurrence of ALT. CONCLUSIONS: We demonstrate that ATRX is mutated in only a subset of ALT+ pHGGs, suggesting other mechanisms of ATRX loss of function or alterations in other genes may be associated with the development of ALT in these patients. We show that germline variants in MMR are associated with the development of ALT in patients with pHGG.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Stundon JL, Ijaz H, Gaonkar KS, et al. Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. Neuro Oncol. 2023. PMID: 36541551. doi:10.1093/neuonc/noac278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。